SSAO inhibitors suppress hepatocellular tumor growth in mice

Cellular Immunology

Volumn 283, Issue 1-2, 2013, Pages 61-69

  Li, Rui ^a   Li, Hui ^a   Luo, Hong Jun ^a   Lin, Zhe Xuan ^a   Jiang, Zhi Wu ^a   Luo, Wen Hong ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Myeloid derived suppressor cells; Neo angiogenesis; SSAO inhibitors; Tumor growth; Vascular adhesion protein 1

Indexed keywords

ANTINEOPLASTIC AGENT; CD11B ANTIGEN; HYDRALAZINE; LJP 1207; SEMICARBAZIDE; UNCLASSIFIED DRUG; VASCULAR ADHESION PROTEIN 1;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CATALYSIS; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; SUPPRESSOR CELL; TUMOR GROWTH; TUMOR VOLUME;

HYD; HYDRALAZINE; LJP1207; MAO-A; MAO-B; MDSCS; MONOAMINE OXIDASE-A; MONOAMINE OXIDASE-B; MYELOID-DERIVED SUPPRESSOR CELLS; N′-[2-PHENYL-ALLYL]-HYDRAZINE HYDROCHLORIDE; NEO-ANGIOGENESIS; PBS; PHOSPHATE BUFFER SALINE; SEM; SEMICARBAZIDE; SEMICARBAZIDE-SENSITIVE AMINE OXIDASE; SSAO; SSAO INHIBITORS; TUMOR GROWTH; VAP-1; VASCULAR ADHESION PROTEIN-1;

AMINE OXIDASE (COPPER-CONTAINING); ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MICE; MICE, INBRED C57BL;

EID: 84880348419     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2013.06.005     Document Type: Article

References (29)

1. Boomsma F., Hut H., Bagghoe U., Houwen A., Meiracker A. Semicarbazide-sensitive amine oxidase (SSAO): from cell to circulation. Med. Sci. Monit. 2005, 11:122-126.
2. Lin Z.X., Han M., Li H., Luo H.J., Zhang Y., Luo W.H. Soluble vascular adhesion protein-1: decreased activity in the plasma of trauma victims and predictive marker for severity of traumatic brain injury. Clin. Chim. Acta. 2011, 412:1678-1682.
3. Dunkel P., Balogh B., Meleddu R., Maccioni E., Gyires K., Mátyus P. Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1: a patent survey. Exp. Opin. Ther. Pat. 2011, 21:1453-1471.
4. Koskinen K., Nevalainen S., Karikoski M., Hanninen A., Jalkanen S., Salmi M. VAP-1-deficient mice display defects in mucosal immunity and antimicrobial responses: implications for antiadhesive applications. J. Immunol. 2007, 179:6160-6168.
5. Salmi M., Tohka S., Berg E.L., Butcher E.C., Jalkanen S. Vascular adhesion protein 1 (VAP-1) mediates lymphocyte subtype-specific, selectin-independent recognition of vascular endothelium in human lymph nodes. J. Exp. Med. 1997, 186:589-600.
6. Han M.Y., Xu J.Y., Bi Y.L., Jiang M., Xu X.Y., Liu Q., Jia J.H. Primary tumor regulates the pulmonary microenvironment in melanoma carcinoma model and facilitates lung metastasis. J. Cancer Res. Clin. Oncol. 2013, 139:57-65.
7. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444.
8. Ruffell B., Affara N.I., Coussens L.M. Differential macrophage programming in the tumor microenvironment. Trends Immunol. 2012, 33:119-126.
9. Bhattacharyya S., Md-Sakib-Hossain D., Mohanty S., Mohanty S., Sankar-Sen G., Chattopadhyay S., Banerjee S., Chakraborty J., Das K., Sarkar D., Das T., Sa G. Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts. Cell Mol. Immunol. 2010, 7:306-315.
10. Marigo I., Bosio E., Solito S., Mesa C., Fernandez A., Dolcetti L., Ugel S., Sonda N., Bicciato S., Falisi E., Calabrese F., Basso G., Zanovello P., Cozzi E., Mandruzzato S., Bronte V. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 2010, 32:790-802.
11. Bronte V. Myeloid-derived suppressor cells in inflammation: uncovering cell subsets with enhanced immunosuppressive functions. Eur. J. Immunol. 2009, 39:2670-2672.
12. Nakao S., Noda K., Zandi S., Sun D., Taher M., Schering A., Xie F., Mashima Y., Hafezi-Moghadam A. VAP-1-mediated M2 macrophage infiltration underlies IL-1beta- but not VEGF-A-induced lymph- and angiogenesis. Am. J. Pathol. 2011, 178:1913-1921.
13. Ribechini E., Greifenberg V., Sandwick S., Lutz M.B. Subsets, expansion and activation of myeloid-derived suppressor cells. Med. Microbiol. Immunol. 2010, 199:273-281.
14. Yoong K.F., McNab G., Hubscher S.G., Adams D.H. Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumor-infiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma. J. Immunol. 1998, 160:3978-3988.
15. Irjala H., Salmi M., Alanen K., Grenman R., Jalkanen S. Vascular adhesion protein 1 mediates binding of immunotherapeutic effector cells to tumor endothelium. J. Immunol. 2001, 166:6937-6943.
16. Jakobsson E., Nilsson J., Ogg D., Kleywegt G.J. Structure of human semicarbazide-sensitive amine oxidase/vascular adhesion protein-1. Acta Crystallogr. D. Biol. Crystallogr. 2005, 61:1550-1562.
17. Salmi M., Jalkanen S. Human vascular adhesion protein 1 (VAP-1) is a unique sialoglycoprotein that mediates carbohydrate-dependent binding of lymphocytes to endothelial cells. J. Exp. Med. 1996, 183:569-579.
18. Salmi M., Tohka S., Jalkanen S. Human vascular adhesion protein-1 (VAP-1) plays a critical role in lymphocyte-endothelial cell adhesion cascade under shear. Circ. Res. 2000, 86:1245-1251.
19. Ekblom J., Gronvall J., Lennernas B., Nilsson S., Garpenstrand H., Oreland L. Elevated activity of semicarbazide-sensitive amine oxidase in blood from patients with skeletal metastases of prostate cancer. Clin. Sci. (Lond) 1999, 97:111-115.
20. Kiss J., Jalkanen S., Fulop F., Savunen T., Salmi M. Ischemia-reperfusion injury is attenuated in VAP-1-deficient mice and by VAP-1 inhibitors. Eur. J. Immunol. 2008, 38:3041-3049.
21. Marttila-Ichihara F., Auvinen K., Elima K., Jalkanen S., Salmi M. Vascular adhesion protein-1 enhances tumor growth by supporting recruitment of Gr-1+CD11b+ myeloid cells into tumors. Cancer Res. 2009, 69:7875-7883.
22. Marttila-Ichihara F., Castermans K., Auvinen K., Oude-Egbrink M.G., Jalkanen S., Griffioen A.W., Salmi M. Small-molecule inhibitors of vascular adhesion protein-1 reduce the accumulation of myeloid cells into tumors and attenuate tumor growth in mice. J. Immunol. 2010, 184:3164-3173.
23. Li H., Luo W.H., Lin J., Lin Z.X., Zhang Y. Assay of plasma semicarbazide-sensitive amine oxidase and determination of its endogenous substrate methylamine by liquid chromatography, J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2004, 810:277-282.
24. Yang W., Li H., Luo H.J., Luo W.H. Inhibition of semicarbazide-sensitive amine oxidase attenuates myocardial ischemia-reperfusion injury in an in vivo rat model. Life Sci. 2011, 88:302-306.
25. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat. 1995, 36:169-180.
26. Jalkanen S., Karikoski M., Mercier N., Koskinen K., Henttinen T., Elima K., Salmivirta K., Salmi M. The oxidase activity of vascular adhesion protein-1 (VAP-1) induces endothelial E- and P-selectins and leukocyte binding. Blood 2007, 110:1864-1870.
27. Johnston B., Kanwar S., Kubes P. Hydrogen peroxide induces leukocyte rolling: modulation by endogenous antioxidant mechanisms including NO. Am. J. Physiol. 1996, 271:H614-621.
28. Cai H. Hydrogen peroxide regulation of endothelial function: Origins, mechanisms, and consequences. Cardiovasc. Res. 2005, 68:26-36.
29. O'Sullivan J., O'Sullivan M., Tipton K.F., Unzeta M., Del Mar Hernandez M., Davey G.P. The inhibition of semicarbazide-sensitive amine oxidase by aminohexoses. Biochim. Biophys. Acta 2003, 1647:367-371.